Pathstone Family Office’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | $285K | Hold |
|
|||||
|
2023
Q2 | $306K | Hold |
|
|||||
|
2023
Q1 | $314K | Sell |
|
|||||
|
2022
Q4 | $635K | Hold |
|
|||||
|
2022
Q3 | $590K | Buy |
|
|||||
|
2022
Q2 | $289K | Hold |
|
|||||
|
2022
Q1 | $310K | Hold |
|
|||||
|
2021
Q4 | $356K | Hold |
|
|||||
|
2021
Q3 | $374K | Sell |
|
|||||
|
2021
Q2 | $425K | Hold |
|
|||||
|
2021
Q1 | $406K | Buy |
|